Small Business Translator: MedTech and Digital Health Technologies
About
Small Business Translator: MedTech and Digital Health Technologies is a federal funding opportunity from National Institutes of Health. This forecasted grant opportunity (FOR-NS-25-017) is available nationwide for eligible applicants.
The Small Business Translator: MedTech and Digital Health Technologies grant, offered by the National Institutes of Health (NIH), is a federal funding opportunity designed to support innovative small businesses developing cutting-edge medical technology and digital health solutions. This forecasted grant program (FOR-NS-25-017) is available to eligible applicants nationwide, making it accessible to entrepreneurs and small business owners across the United States who are working on breakthrough technologies in the healthcare sector. The program aims to accelerate the translation of research into commercially viable products and services that can improve patient outcomes and advance the healthcare industry. Small business owners in the medtech and digital health space should apply because this grant provides critical funding to bridge the gap between research and market commercialization. Whether you're developing diagnostic tools, therapeutic devices, health information systems, or digital platforms that improve healthcare delivery, this opportunity can provide the financial resources needed to move your technology forward. The NIH recognizes the vital role small businesses play in healthcare innovation and offers this program to help promising companies overcome funding barriers during critical development phases. For entrepreneurs with strong scientific foundations and commercial potential, this grant represents a valuable pathway to secure federal support without sacrificing equity in their companies.
Grant Details
Funding Range
Varies by cycle; see official announcement FOR-NS-25-017
Grant Type
Federal
Application Cycle
Forecasted opportunity; check NIH website for current cycle details
Best For
Small businesses developing medical devices, diagnostic tools, therapeutic technologies, and digital health solutions
Frequently Asked Questions
Who is eligible for Small Business Translator: MedTech and Digital Health Technologies?
Specific eligibility criteria have not been provided in available information. Typically, NIH small business grants require applicants to be U.S.-based small businesses meeting SBA size standards. For detailed and current eligibility requirements, including business size limits, citizenship requirements, and specific qualifications for medtech and digital health projects, visit the official NIH grants website or the specific funding announcement FOR-NS-25-017.
How much funding does Small Business Translator: MedTech and Digital Health Technologies provide?
Specific funding amounts have not been disclosed in the available information. Grant amounts typically vary depending on the project scope, phase of development, and funding cycle. Visit the official NIH Small Business grants portal or the specific funding opportunity announcement (FOR-NS-25-017) to find current funding ranges and project budget limits.
How do I apply for Small Business Translator: MedTech and Digital Health Technologies?
Applications are typically submitted through the NIH grants portal (grants.nih.gov) using the ASSIST system or comparable submission platform. You will need to prepare a detailed project proposal, budget justification, and supporting documentation specific to your medtech or digital health innovation. For step-by-step application instructions, deadlines, and required documentation, consult the official funding opportunity announcement FOR-NS-25-017 on the NIH website or contact your local Small Business Development Center for guidance.
What can Small Business Translator: MedTech and Digital Health Technologies funding be used for?
Based on the program's focus on medtech and digital health translation, funding is intended to support the development, validation, and commercialization of medical devices, diagnostic tools, therapeutic technologies, and digital health solutions. This typically includes research and development, prototype refinement, regulatory pathway planning, clinical validation studies, and activities that move innovations toward market readiness. For a comprehensive list of allowable uses and budget categories, review the specific funding opportunity announcement from the NIH.
Last updated: March 1, 2026